Compare Vanguard Intermediate Term Corporate Bond ETF (VCIT) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Intermediate Term Corporate Bond ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Vanguard Intermediate Term Corporate Bond ETF trades at $78.53 (market cap $72.20B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vanguard Intermediate Term Corporate Bond ETF is far larger — about 40.1× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Intermediate Term Corporate Bond ETF for 64 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| VCIT | VIR | |
|---|---|---|
Market Cap | $72.20B | $1.80B |
Volume | 9,562,318 | 1,782,836 |
Sector | Fixed Income | Health |
52-Week High | $84.82 | $11.78 |
52-Week Low | $77.98 | $5.12 |
Typical Hold Time | 64 Days | 0 Days |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VCIT trades at $78.48, down slightly by 0.03% with a bullish technical signal supported by oscillators despite bearish moving averages. The ETF maintains consistent dividend payments of $0.34 per share and shows strong institutional interest with recent purchases by Engineers Gate Manager LP and HB Wealth Management. Technical analysis indicates key support at $78 and resistance at $80.
VCIT offers a compelling risk-return profile with a 4.8% yield and 5.1% yield to maturity, benefiting from low 0.03% expense ratio. Risks include interest rate sensitivity and corporate credit exposure, but the fund's intermediate-term corporate bond focus provides balanced income generation for investors seeking steady returns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
